ID   SRSF1_BOVIN             Reviewed;         248 AA.
AC   Q0VCY7;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2006, sequence version 1.
DT   07-APR-2021, entry version 116.
DE   RecName: Full=Serine/arginine-rich splicing factor 1;
DE   AltName: Full=Splicing factor, arginine/serine-rich 1;
GN   Name=SRSF1; Synonyms=SFRS1;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Hereford; TISSUE=Fetal skin;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Plays a role in preventing exon skipping, ensuring the
CC       accuracy of splicing and regulating alternative splicing. Interacts
CC       with other spliceosomal components, via the RS domains, to form a
CC       bridge between the 5'- and 3'-splice site binding components, U1 snRNP
CC       and U2AF. Can stimulate binding of U1 snRNP to a 5'-splice site-
CC       containing pre-mRNA. Binds to purine-rich RNA sequences, either the
CC       octamer, 5'-RGAAGAAC-3' (r=A or G) or the decamers,
CC       AGGACAGAGC/AGGACGAAGC. Binds preferentially to the 5'-CGAGGCG-3' motif
CC       in vitro. Three copies of the octamer constitute a powerful splicing
CC       enhancer in vitro, the ASF/SF2 splicing enhancer (ASE) which can
CC       specifically activate ASE-dependent splicing. May function as export
CC       adapter involved in mRNA nuclear export through the TAP/NXF1 pathway
CC       (By similarity). {ECO:0000250|UniProtKB:Q07955}.
CC   -!- SUBUNIT: Consists of two polypeptides of p32 and p33. In vitro, self-
CC       associates and binds SRSF2, SNRNP70 and U2AF1 but not U2AF2. Binds
CC       SREK1/SFRS12. Interacts with SAFB/SAFB1. Interacts with PSIP1/LEDGF.
CC       Interacts with SRPK1. Identified in the spliceosome C complex.
CC       Interacts with RSRC1 (via Arg/Ser-rich domain). Interacts with
CC       ZRSR2/U2AF1-RS2. Interacts with CCDC55 (via C-terminus). Interacts with
CC       SRPK1 and a sliding docking interaction is essential for its sequential
CC       and processive phosphorylation by SRPK1. Interacts with NXF1. Interacts
CC       with CCNL1, CCNL2 and CDK11B. Interacts with RRP1B. Interacts (when
CC       phosphorylated in its RS domain) with TNPO3; promoting nuclear import.
CC       {ECO:0000250|UniProtKB:Q07955}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q07955}. Nucleus
CC       speckle {ECO:0000250|UniProtKB:Q07955}. Note=In nuclear speckles.
CC       Shuttles between the nucleus and the cytoplasm. Nuclear import is
CC       mediated via interaction with TNPO3. {ECO:0000250|UniProtKB:Q07955}.
CC   -!- DOMAIN: The RRM 2 domain plays an important role in governing both the
CC       binding mode and the phosphorylation mechanism of the RS domain by
CC       SRPK1. RS domain and RRM 2 are uniquely positioned to initiate a highly
CC       directional (C-terminus to N-terminus) phosphorylation reaction in
CC       which the RS domain slides through an extended electronegative channel
CC       separating the docking groove of SRPK1 and the active site. RRM 2 binds
CC       toward the periphery of the active site and guides the directional
CC       phosphorylation mechanism. Both the RS domain and an RRM domain are
CC       required for nucleocytoplasmic shuttling (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated by CLK1, CLK2, CLK3 and CLK4. Phosphorylated by
CC       SRPK1 at multiple serines in its RS domain via a directional (C-
CC       terminal to N-terminal) and a dual-track mechanism incorporating both
CC       processive phosphorylation (in which the kinase stays attached to the
CC       substrate after each round of phosphorylation) and distributive
CC       phosphorylation steps (in which the kinase and substrate dissociate
CC       after each phosphorylation event). The RS domain of SRSF1 binds to a
CC       docking groove in the large lobe of the kinase domain of SRPK1 and this
CC       induces certain structural changes in SRPK1 and/or RRM 2 domain of
CC       SRSF1, allowing RRM 2 to bind the kinase and initiate phosphorylation.
CC       The cycles continue for several phosphorylation steps in a processive
CC       manner (steps 1-8) until the last few phosphorylation steps
CC       (approximately steps 9-12). During that time, a mechanical stress
CC       induces the unfolding of the beta-4 motif in RRM 2, which then docks at
CC       the docking groove of SRPK1. This also signals RRM 2 to begin to
CC       dissociate, which facilitates SRSF1 dissociation after phosphorylation
CC       is completed (By similarity). {ECO:0000250}.
CC   -!- PTM: Asymmetrically dimethylated at arginines, probably by PRMT1,
CC       methylation promotes localization to nuclear speckles. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the splicing factor SR family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC119930; AAI19931.1; -; mRNA.
DR   RefSeq; NP_001069862.1; NM_001076394.1.
DR   BMRB; Q0VCY7; -.
DR   SMR; Q0VCY7; -.
DR   STRING; 9913.ENSBTAP00000046374; -.
DR   iPTMnet; Q0VCY7; -.
DR   PaxDb; Q0VCY7; -.
DR   PeptideAtlas; Q0VCY7; -.
DR   PRIDE; Q0VCY7; -.
DR   Ensembl; ENSBTAT00000049486; ENSBTAP00000046374; ENSBTAG00000014766.
DR   GeneID; 615796; -.
DR   KEGG; bta:615796; -.
DR   CTD; 6426; -.
DR   VGNC; VGNC:35297; SRSF1.
DR   eggNOG; KOG0105; Eukaryota.
DR   GeneTree; ENSGT00940000155585; -.
DR   HOGENOM; CLU_012062_34_0_1; -.
DR   InParanoid; Q0VCY7; -.
DR   OMA; VDCRVMT; -.
DR   OrthoDB; 1321443at2759; -.
DR   TreeFam; TF106261; -.
DR   Proteomes; UP000009136; Chromosome 19.
DR   Bgee; ENSBTAG00000014766; Expressed in spleen and 18 other tissues.
DR   ExpressionAtlas; Q0VCY7; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005681; C:spliceosomal complex; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; ISS:UniProtKB.
DR   GO; GO:0000380; P:alternative mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0000395; P:mRNA 5'-splice site recognition; ISS:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
DR   CDD; cd12597; RRM1_SRSF1; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR034520; SRSF1_RRM1.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   2: Evidence at transcript level;
KW   Acetylation; Cytoplasm; Isopeptide bond; Methylation; mRNA processing;
KW   mRNA splicing; mRNA transport; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat; RNA-binding; Spliceosome; Transport; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   CHAIN           2..248
FT                   /note="Serine/arginine-rich splicing factor 1"
FT                   /id="PRO_0000287724"
FT   DOMAIN          16..91
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          121..195
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          198..247
FT                   /note="Interaction with SAFB1"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        94..113
FT                   /note="Gly-rich (hinge region)"
FT   COMPBIAS        198..247
FT                   /note="Arg/Ser-rich (RS domain)"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955, ECO:0000255"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         38
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         93
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         93
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         97
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         97
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         109
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         109
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         111
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         133
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         179
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         199
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         201
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         202
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         205
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         207
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         209
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         231
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         234
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   MOD_RES         238
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   CROSSLNK        30
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
FT   CROSSLNK        38
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q07955"
SQ   SEQUENCE   248 AA;  27745 MW;  C28A0B2F112EA713 CRC64;
     MSGGGVIRGP AGNNDCRIYV GNLPPDIRTK DIEDVFYKYG AIRDIDLKNR RGGPPFAFVE
     FEDPRDAEDA VYGRDGYDYD GYRLRVEFPR SGRGTGRGGG GGGGGGAPRG RYGPPSRRSE
     NRVVVSGLPP SGSWQDLKDH MREAGDVCYA DVYRDGTGVV EFVRKEDMTY AVRKLDNTKF
     RSHEGETAYI RVKVDGPRSP SYGRSRSRSR SRSRSRSRSN SRSRSYSPRR SRGSPRYSPR
     HSRSRSRT
//
